State psychedelics legalization and policy roundup — October 2025

This post is part of an ongoing series summarizing state-based psychedelic reforms intended for policy professionals.

Kentucky

On Aug. 27, the Interim Joint Committee on Health Services discussed whether Kentucky should join a multi-state collaborative to conduct clinical trials of ibogaine as a treatment for certain neurological conditions, including opioid addiction. In 2023, the Kentucky Opioid Abatement Advisory Commission first broached the idea of directing a portion of the state’s ...

Continue Reading →
feature-image

Joe Rogan Hails “Psychedelic” Texas Initiative That Could’ve Changed ‘The Smashing Machine’ Mark Kerr’s Life

“Once you turn that invisible line, there’s no going back,” said UFC legend Mark Kerr, speaking to Sports Illustrated about his addiction. Fans knew him as ‘The Smashing Machine.’ Kerr captured two UFC heavyweight titles after debuting in the promotion in 1997. At his peak, he dominated opponents and looked unstoppable inside the Octagon. However, away from the spotlight, his life veered into a darker fight. Kerr battled prescription painkillers and ...

Continue Reading →

Athletes Turn to Banned Ibogaine for CTE and Concussion Relief

In the high-stakes world of professional sports, where concussions and chronic traumatic encephalopathy (CTE) cast long shadows over athletes’ careers and post-retirement lives, a controversial treatment is gaining quiet traction among NFL and UFC veterans. Ibogaine, a potent psychedelic derived from the African iboga shrub, is being sought out by players desperate for relief from brain trauma symptoms, despite its classification as a Schedule 1 controlled substance in the U.S. with no approved ...

Continue Reading →

Some Athletes are Trying the Psychedelic Ibogaine to Treat Brain Injuries

“As awareness grows around the dangers of head trauma in sports, a small number of professional fighters and football players are turning to a psychedelic called ibogaine for treatment,” reports the Los Angeles Times.

They note that the drug’s proponents “tout its ability to treat addiction, post-traumatic stress disorder and traumatic brain injury, or TBI. ”

Ibogaine, which is derived from a West African shrub, is a Schedule ...

Continue Reading →
Page 35 of 136 «...1020303334353637...»
UA-77446339-1